![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 47/54 | |
A61P 5/00 |
(11) | Number of the document | 2525834 |
(13) | Kind of document | T |
(96) | European patent application number | 11705470.0 |
Date of filing the European patent application | 2011-01-24 | |
(97) | Date of publication of the European application | 2012-11-28 |
(45) | Date of publication and mention of the grant of the patent | 2019-07-17 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2011/050923 |
Date | 2011-01-24 |
(87) | Number | WO 2011/089255 |
Date | 2011-07-28 |
(30) | Number | Date | Country code |
297305 P | 2010-01-22 | US | |
10151405 | 2010-01-22 | EP |
(72) |
BEHRENS, Carsten, DK
JOHANSEN, Nils Langeland, DK
ANDERSEN, Henrik Sune, DK
N RSKOV-LAURITSEN, Leif, DK
BUCHARDT, Jens, DK
|
(73) |
Novo Nordisk Health Care AG,
Thurgauerstrasse 36/38 8050 Zürich,
CH
|
(54) | GROWTH HORMONES WITH PROLONGED IN-VIVO EFFICACY |
GROWTH HORMONES WITH PROLONGED IN-VIVO EFFICACY |